With a rapid increase in the size of the aging population, obesity rising at an alarming rate, and sedentary lifestyles becoming more common, diabetes has evolved into one of the most devastating diseases that affects millions of people worldwide. According to a survey conducted by the World Health Organization (WHO), an estimated 422 million people…
One of the emerging markets in the pharmaceutical industry, the pediatric medicines market requires a huge amount of investments and R&D activities. One major reason behind the growing demand for pediatric medicines is the fact that the birth rate has increased rapidly – both in the developed as well as the developing nations. Also with…
While it is true that no specific drug has been approved for the treatment of Celiac disease, there are some anti-inflammatory and immunosuppressant medications and nutritional supplements that are consumed as off-label therapy in celiac disease. Celiac disease is an autoimmune inflammatory disease of the small intestine, which is triggered by intake of gluten from…
Infantile spasms (IS), though a rare occurrence, is surely one of the most dreaded medical conditions for a baby and its parents. Recent reports show that in majority cases, it is a delay in diagnosis of the disorder which makes treatment even more difficult for the child. Also known as West Syndrome, IS is a…
Analysts at Technavio expect the global pharmaceutical contract manufacturing market to grow at a CAGR of around 7% by 2020.
According to analysts at Technavio, the global over-the-counter drug market will reach $162 billion by 2020, growing at a CAGR of 6.37%.
According to analysts at Technavio, the Chinese rhEPO market is poised to record a CAGR of nearly 17% by the year 2020.
